Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

NeuroMetrix Q3 GAAP EPS $(0.21) Up From $(0.23) YoY, Sales $1.20M Down From $1.97M YoY

Author: Benzinga Newsdesk | October 26, 2023 07:06am
NeuroMetrix (NASDAQ:NURO) reported quarterly losses of $(0.21) per share. This is a 8.7 percent increase over losses of $(0.23) per share from the same period last year. The company reported $1.20 million in sales this quarter. This is a 38.87 percent decrease over sales of $1.97 million the same period last year.

Posted In: NURO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist